pTAL5-BB
(Plasmid
#36033)
-
Purpose(Empty Backbone)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 36033 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepTAL3
-
Backbone manufacturerAddgene
- Backbone size (bp) 7530
-
Modifications to backboneThe pTAL5 plasmid was constructed using the Gibson method to assemble four sections into an ordered plasmid; 1 - PGAL1 was amplified from S. cerevisiae YPH500 genomic DNA. 2 - The TALEN destination protein coding sequence minus the FokI domain was amplified from pTAL3. 3 - The ADH1 terminator was amplified from pTVGI. 4 - The pTAL3 vector backbone was amplified as a linear fragment.
-
Vector typeYeast Expression
- Promoter PGAL1
-
Selectable markersHIS3
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH10B
-
Copy numberHigh Copy
Resource Information
-
A portion of this plasmid was derived from a plasmid made byPlasmid derived from pTAL3 from Addgene TALEN Golden Gate cloning kit.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
For more information on Ellis TALEN Add-On Plasmids please refer to: http://www.addgene.org/TALeffector/goldengate/add-ons/#ellis
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pTAL5-BB was a gift from Tom Ellis (Addgene plasmid # 36033 ; http://n2t.net/addgene:36033 ; RRID:Addgene_36033) -
For your References section:
Rational diversification of a promoter providing fine-tuned expression and orthogonal regulation for synthetic biology. Blount BA, Weenink T, Vasylechko S, Ellis T. PLoS One. 2012;7(3):e33279. Epub 2012 Mar 19. 10.1371/journal.pone.0033279 PubMed 22442681